Targeted antigen delivery to antigen–presenting cells including dendritic cells by engineered Fas-mediated apoptosis

Janeway, C. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunology Today 13, 11–16 (1992).

Matzinger, P. Tolerance, danger, and the extended family. Ann. Rev. Immunol. 12, 991–1045 (1994).

Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5, 1249–1255 (1999).

Sigal, L.J., Crotty, R., Andino, R. & Rock, K. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 398, 77–80 (1999).

Albert, M., Sauter, B. & Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86–89 (1998).

Mitchell, D., Nair, S. & Gilboa, E. Dendritic cell/macrophage prescursors capture exogenous antigen for MHC class I presentation by dendritic cells. Eur. J. Immunol. 28, 1923–1933 (1998).

Kim, J., Tsai, A., Nottingham, L., Morrison, L. & Cunning, D. Intracellular Adhesion Molecule-1 (ICAM-1) modulates β-chemokines and provides costimulatory signals required for T-cell activation and expansion in vivo. J. Clin. Invest. 103, 869–877 (1999).

Kim, J. et al. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines. J. Clin. Invest. 102, 1112–1124 (1998).

Kim, J. et al. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat. Biotechnol. 15, 641–646 (1997).

Chattergoon, M., Robinson, T., Boyer, J. & Weiner, D. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages. J. Immunol. 160, 5707–5718 (1998).

Agadjanyan, M. et al. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. J. Immunol. 162, 3417–3427 (1999).

Porgador, A. et al. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T-cells after gene gun immunization. J. Exp. Med. 188, 1075–1082 (1998).

Coney, L. et al. Facilitated DNA inoculation induces anti-HIV immunity in vivo. Vaccines 12, 1545–1550 (1994).

Takahashi, H. et al. Induction of broadly cross-reactive cytotoxic T–cells recognizing an HIV-1 envelope determinant. Science 255, 333–336 (1992).

Shirai, M., Pendleton, C. & Berzofsky, J. Broad recognition of cytotoxic T-cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. J. Immunol. 148, 1657–1667 (1992).

Mogensen, S. & Virelizier, J. The interferon–macrophage alliance [Review]. Inteferon 8, 55–84 (1987).

Seder, R. & Paul, W. Acquisition of lymphokine-producing phenotype by CD4+ T-cells. Ann. Rev. Immunol. 12, 635–673 (1994).

Banchereau, J. & Steinman, R. Dendritic cells and the control of immunity. Nature 392, 245–252 (1998).

Porgador, A., Snyder, D. & Gilboa, E. Induction of antitumor immunity using bone marrow–generated dendritic cells. J. Immunol. 156, 2918–2926 (1996).

Celluzzi, C.M., Mayordomo, J.I., Storkus, W.J., Lotze, M.T. & Falo, L.D.J. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183, 283–287 (1996).

Mayordomo, J.I. et al. Bone marrow–derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines. Stem Cells 15, 94–103. (1997).

Hsu, F.J. et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 52–58 (1996).

Murphy, G., Tjoa, B., Ragde, H., Kenny, G. & Boynton, A. Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201–specific peptides from prostate-specific membrane antigen. Prostate 29, 371–380 (1996).

Nestle, F.O. et al. Vaccination of melanoma patients with peptide- or tumor lysate–pulsed dendritic cells. Nat. Med. 4, 328–332 (1998).

Nagata, S. & Goldstein, P. The Fas death factor. Science 267, 1449–1456 (1995).

Trauth, B. et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301–305 (1989).

Vignaux, F. et al. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181, 781–786 (1995).

Matzinger, P. An innate sense of danger. Semin. Immunol. 10, 399–415 (1998).

Kim, J.J. et al. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 28, 1089–1103 (1998).

Kim, J. et al. Molecular and immunological analysis of genetic prostate-specific antigen. Oncogene 17, 3125–3135 (1999).